# Fatty Liver Disease in Obese Children

> **NCT02117700** · PHASE1,PHASE2 · COMPLETED · sponsor: **Nemours Children's Clinic** · enrollment: 14 (actual)

## Conditions studied

- Obesity
- Nonalcoholic Fatty Liver Disease
- Cardiovascular Disease

## Interventions

- **DIETARY_SUPPLEMENT:** N-acetyl cysteine 600 mg once/day
- **DIETARY_SUPPLEMENT:** N-acetyl cysteine 600mg twice/day
- **OTHER:** Placebo twice/day

## Key facts

- **NCT ID:** NCT02117700
- **Lead sponsor:** Nemours Children's Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2018-04
- **Final completion:** 2020-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02117700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02117700, "Fatty Liver Disease in Obese Children". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT02117700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*